Clinical Trials Directory

Trials / Unknown

UnknownNCT02406898

Evaluation of a Hysteroscopic Morcellator in Hysteroscopic Treatment of Submucosal Fibroids

Operative Hysteroscopy for Fibroma by Classic Resection Versus Morcellation: a Ramdomised Study

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
Assistance Publique Hopitaux De Marseille · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

Hysteroscopic surgery is the gold standard for intra uterine pathology especially fibroma. Limit of this technic is duration of procedure which is correlated to operative complications. So, for patient with large fibrome or several fibromas, this technic is not indicated or performs in several times. A new technic of hysteroscopic surgery is available which is quicker than conventional technic. This technic is poorly evaluated. Aim of this study is to evaluate both technics on procedure duration.

Detailed description

Material and Methods We propose a monocentric-randomised study. Inclusion criteria are women over 18 years requiring hysteroscopic surgery for fibroma. After informed consent, patients will be randomised in two groups: hysteroscopic surgery with morcellation technic and conventional hysteroscopy technic with resection. The main objective is duration of procedure. Secondary objectives are characteristics and perioperative complications (distension media quantity, cervical injury, uterine perforation), immediate et long term postoperative data's (postoperative pain and synechia). We hypothesis hysteroscopic with morcellation reduces duration of procedure of 50%. The estimated size of population number is 30 per group and 60 for the study. Expected results We expected a significant decrease of procedure duration with hysteroscopic morcellation. This data will be interesting according peroperative complications are correlated to procedure duration and allow hysteroscopic surgery to patients with large or several fibromas.

Conditions

Interventions

TypeNameDescription
DEVICEmorcellator uterine system (MH)Karl Storz, Tuttligen- Germany

Timeline

Start date
2015-04-01
Primary completion
2017-03-01
Completion
2018-03-01
First posted
2015-04-02
Last updated
2015-09-29

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT02406898. Inclusion in this directory is not an endorsement.